Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

114.64

+2.10 (1.87%)

At close: Jun 18, 2025, 4:00 PM

100.00

-14.64 (-12.77%)

After-hours: Jun 18, 2025, 6:07 PM EDT

Ligand Pharmaceuticals Market Cap

Ligand Pharmaceuticals has a market cap or net worth of $2.21 billion as of June 18, 2025. Its market cap has increased by 40.06% in one year.

Market Cap

2.21B

Enterprise Value

2.01B

1-Year Change

40.06%

Ranking

#1843

Market Cap Chart

Since December 1, 1998, Ligand Pharmaceuticals's market cap has increased from $430.80M to $2.21B, an increase of 413.44%. That is a compound annual growth rate of 6.35%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	2.21B	9.25%
Dec 31, 2024	2.02B	62.58%
Dec 29, 2023	1.25B	10.35%
Dec 30, 2022	1.13B	-56.28%
Dec 31, 2021	2.58B	61.30%
Dec 31, 2020	1.60B	-12.63%
Dec 31, 2019	1.83B	-36.49%
Dec 31, 2018	2.88B	-0.20%
Dec 29, 2017	2.89B	36.08%
Dec 30, 2016	2.12B	-1.70%
Dec 31, 2015	2.16B	102.78%
Dec 31, 2014	1.07B	-0.76%
Dec 31, 2013	1.07B	159.26%
Dec 31, 2012	414.10M	77.34%
Dec 30, 2011	233.50M	33.50%
Dec 31, 2010	174.90M	-28.67%
Dec 31, 2009	245.20M	-5.73%
Dec 31, 2008	260.10M	-43.57%
Dec 31, 2007	460.90M	-46.88%
Dec 29, 2006	867.60M	4.96%
Dec 30, 2005	826.60M	-3.95%
Dec 31, 2004	860.60M	-19.85%
Dec 31, 2003	1.07B	179.68%
Dec 31, 2002	383.90M	-64.11%
Dec 31, 2001	1.07B	34.96%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	710.32B
Johnson & Johnson	366.64B
Novo Nordisk	334.60B
AbbVie	327.63B
UnitedHealth Group	280.19B
Abbott Laboratories	230.15B
Novartis AG	229.92B
AstraZeneca	223.18B

Market Cap Rankings